Cargando…
Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome
OBJECTIVE: To evaluate current evidence on the efficacy and safety of topical and systemic medications in patients with primary Sjögren syndrome (SjS) to inform European League Against Rheumatism treatment recommendations. METHODS: The MEDLINE, EMBASE and Cochrane databases were searched for case-co...
Autores principales: | Brito-Zerón, Pilar, Retamozo, Soledad, Kostov, Belchin, Baldini, Chiara, Bootsma, Hendrika, De Vita, Salvatore, Dörner, Thomas, Gottenberg, Jacques-Eric, Kruize, Aike A., Mandl, Thomas, Ng, Wan-Fai, Seror, Raphaele, Tzioufas, Athanasios G., Vitali, Claudio, Bowman, Simon, Mariette, Xavier, Ramos-Casals, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827762/ https://www.ncbi.nlm.nih.gov/pubmed/31749986 http://dx.doi.org/10.1136/rmdopen-2019-001064 |
Ejemplares similares
-
Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome
por: Seror, Raphaele, et al.
Publicado: (2022) -
Efficacy and safety of abatacept in active primary Sjögren’s syndrome: results of a phase III, randomised, placebo-controlled trial
por: Baer, Alan N, et al.
Publicado: (2021) -
Characteristics of Sjögren’s syndrome associated with rheumatoid arthritis
por: Hassold, Nolan, et al.
Publicado: (2022) -
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
por: Seror, Raphaèle, et al.
Publicado: (2015) -
Large granular lymphocyte expansions in primary Sjögren’s syndrome: characteristics and outcomes
por: Baber, Alistair, et al.
Publicado: (2019)